肺癌患者bFGF、miR-1233、D-二聚体及Fib水平变化与肺栓塞发生的关系OACSTPCD
The relationship between changes in bFGF,miR-1233,D-dimer,and Fib levels and the occurrence of pulmonary embolism in lung cancer patients
目的 分析碱性成纤维细胞生长因子(bFGF)、微小核糖核酸-1233(miR-1233)、D-二聚体(D-D)、纤维蛋白原(Fib)水平变化与肺癌患者发生肺栓塞的相关性.方法 选取2018 年6 月—2021 年6 月华北理工大学附属医院呼吸内科确诊的肺癌合并肺栓塞患者 110 例作为栓塞组,另外选取医院同期收治的肺癌但未合并肺栓塞患者110 例作为非栓塞组,比较2 组患者入院时的血清bFGF、miR-1233、血浆D-D、Fib水平,凝血功能指标、合并疾病、肺癌病理学指标及其他相关资料;受试者工作特征曲线(ROC)分析bFGF、miR-1233、D-D、Fib预测患者发生肺栓塞的价值;Logistic回归模型分析 bFGF、miR-1233、D-D、Fib 与肺癌患者发生肺栓塞的关系.结果 栓塞组患者 bFGF、miR-1233、D-D、Fib水平均高于非栓塞组(t/P =4.749/<0.001、9.244/<0.001、16.846/<0.001、9.389/<0.001);栓塞组患者的PT、APTT、INR 测定值低于非栓塞组(t/P = 8.131/<0.001、7.875/<0.001、6.379/<0.001);bFGF、miR-1233、D-D、Fib预测肺癌患者发生肺栓塞的ROC曲线下面积(AUC)分别为0.687、0.821、0.947、0.766,以D-D的AUC最大(Z/P =5.102/<0.001、4.910/<0.001、3.776/<0.001);Logistic回归模型分析显示,bFGF、miR-1233、D-D、Fib均升高,合并房颤是肺癌患者发生肺部栓塞的独立危险因素[OR(95%CI)=1.486(1.059~2.086)、1.672(1.128~2.479)、2.018(1.246~3.268)、1.912(1.066~3.428)、2.164(1.298~3.609)],PT、APTT、INR升高为独立保护因素[OR(95%CI)=0.618(0.404~0.946)、0.640(0.428~0.956)、0.501(0.280~0.894)].结论 血清 bFGF、miR-1233、血浆D-D、Fib升高会增大肺癌患者发生肺栓塞的风险,检测上述指标,尤其是D-D水平,对于预测患者发生肺栓塞具有重要的价值.
Objective To analyze the correlation between changes in levels of basic fibroblast growth factor(bF-GF),microribonucleic acid-1233(miR-1233),D-dimer(D-D),and fibrinogen(Fib)and the occurrence of pulmonary embolism in lung cancer patients.Methods One hundred and ten lung cancer patients with pulmonary embolism diagnosed in the Re-spiratory Department of North China University of Technology Affiliated Hospital from June 2018 to June 2021 were selected as the embolism group.In addition,110 lung cancer patients who were admitted to the hospital during the same period but did not have pulmonary embolism were selected as the non-embolism group.The serum bFGF,miR-1233,plasma D-D,Fib levels,coagulation function indicators,comorbidities,lung cancer pathology indicators,and other related data of the two groups of patients were compared at admission;The value of receiver operating characteristic curve(ROC)analysis of bFGF,miR-1233,D-D,and Fib in predicting the occurrence of pulmonary embolism in patients;Logistic regression model was used to analyze the relationship between bFGF,miR-1233,D-D,Fib and the occurrence of pulmonary embolism in lung cancer pa-tients.Results The levels of bFGF,miR-1233,D-D,and Fib in the embolization group were higher than those in the non-embolization group(t/P=4.749/<0.001,9.244/<0.001,16.846/<0.001,9.389/<0.001);The PT,APTT,and INR measurements of patients in the embolization group were lower than those in the non-embolization group(t/P=8.131/<0.001,7.875/<0.001,6.379/<0.001);The areas under the ROC curve(AUC)predicted by bFGF,miR-1233,D-D,and Fib for pulmonary em-bolism in lung cancer patients were 0.687,0.821,0.947,and 0.766,respectively,with D-D having the highest AUC(Z/P= 5.102/<0.001,4.910/<0.001,3.776/<0.001);Logistic regression model analysis showed that bFGF,miR-1233,D-D,and Fib were all elevated,Atrial fibrillation was an independent risk factor for pulmonary embolism in lung cancer patients[OR(95%CI)=1.486(1.059-2.086),1.672(1.128-2.479),2.018(1.246-3.268),1.912(1.066-3.428),2.164(1.298-3.609)],PT,APTT and INR were all elevated was an independent protective factors[OR(95%CI)=0.618(0.404-0.946),0.640(0.428-0.956),0.501(0.280-0.894)].Conclusion Elevated levels of serum bFGF,miR-1233,plasma D-D,and Fib can increase the risk of pulmo-nary embolism in lung cancer patients.Detecting these indicators,especially D-D levels,has important value in predicting the occurrence of pulmonary embolism in patients.
解宝泉;王立民;王袁
063000 唐山,华北理工大学附属医院呼吸内科
临床医学
肺癌肺栓塞碱性成纤维细胞生长因子微小核糖核酸-1233D-二聚体纤维蛋白原
Lung cancerPulmonary embolismBasic fibroblast growth factorMicroribonucleic acid-1233D-dimerFibrinogen
《疑难病杂志》 2024 (001)
41-45 / 5
河北省卫生健康委医学科学研究课题计划(20180781) Medical Science Research Project of Hebei Provincial Health Commission(20180781)
评论